Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000352360 | SCV000394766 | uncertain significance | MHC class II deficiency | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Center for Genomics, |
RCV000352360 | SCV000898613 | uncertain significance | MHC class II deficiency | 2017-11-21 | criteria provided, single submitter | clinical testing | CIITA NM_000246.3 exon 11 p.Arg884His (c.2651G>A): This variant has not been reported in the literature but is present in 0.1% (21/16688) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs374443915). This variant is present in ClinVar (Variation ID:317716). This variant amino acid Histidine (His) is present in >20 species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Fulgent Genetics, |
RCV002487397 | SCV002780155 | uncertain significance | MHC class II deficiency; Rheumatoid arthritis | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000352360 | SCV003247207 | uncertain significance | MHC class II deficiency | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 884 of the CIITA protein (p.Arg884His). This variant is present in population databases (rs374443915, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CIITA-related conditions. ClinVar contains an entry for this variant (Variation ID: 317716). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomics, |
RCV002487397 | SCV003919805 | uncertain significance | MHC class II deficiency; Rheumatoid arthritis | 2021-03-30 | criteria provided, single submitter | clinical testing | CIITA NM_000246 exon 11 p.Arg884His (c.2651G>A): This variant has not been reported in the literature but is present in 0.1% (21/16688) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs374443915). This variant is present in ClinVar (Variation ID:317716). This variant amino acid Histidine (His) is present in >20 species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV004021643 | SCV004927394 | likely benign | Inborn genetic diseases | 2023-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000352360 | SCV001464786 | likely benign | MHC class II deficiency | 2020-04-24 | no assertion criteria provided | clinical testing |